Citadel Advisors’s European Wax Center EWCZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129K Buy
+22,300
New +$111K ﹤0.01% 11811
2025
Q4
Sell
-22,500
Closed -$89.8K 13024
2025
Q3
$89.8K Buy
+22,500
New +$103K ﹤0.01% 11911
2025
Q2
Sell
-19,700
Closed -$77.8K 13227
2025
Q1
$77.8K Sell
19,700
-87,900
-82% -$523K ﹤0.01% 11793
2024
Q4
$718K Buy
107,600
+20,800
+24% +$137K ﹤0.01% 7764
2024
Q3
$590K Buy
86,800
+86,500
+28,833% +$671K ﹤0.01% 7915
2024
Q2
$2.98K Buy
300
+100
+50% +$1.14K ﹤0.01% 13636
2024
Q1
$2.6K Sell
200
-300
-60% -$4.29K ﹤0.01% 13992
2023
Q4
$6.79K Sell
500
-44,600
-99% -$646K ﹤0.01% 13331
2023
Q3
$731K Sell
45,100
-6,800
-13% -$123K ﹤0.01% 7255
2023
Q2
$967K Sell
51,900
-2,000
-4% -$35.8K ﹤0.01% 6526
2023
Q1
$1.02M Buy
53,900
+53,800
+53,800% +$942K ﹤0.01% 6729
2022
Q4
$1.25K Buy
+100
New +$1.44K ﹤0.01% 14503

Other funds holding EWCZ

Citadel Advisors's EWCZ Position: Q1 2026 in Review

Citadel Advisors increased its European Wax Center (EWCZ) stake by 8.7% in Q1 2026, buying an estimated $112K and bringing the position to 280,361 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #6557.

Citadel Advisors first reported a position in EWCZ in Q3 2021 and has held it in 18 quarters since. The position peaked at $11.4M in Q3 2022. 120 funds tracked by Wall St. Rank hold EWCZ as of Q1 2026.

  • Citadel Advisors held 280,361 shares of European Wax Center worth $1.62M as of Q1 2026.
  • Citadel Advisors bought 22,548 European Wax Center shares in Q1 2026, an estimated $112K.
  • European Wax Center made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6557 holding.
  • Citadel Advisors first reported a position in European Wax Center in Q3 2021 and has held it in 18 quarters since.
  • Citadel Advisors's European Wax Center position peaked at $11.4M in Q3 2022.
  • 120 funds tracked by Wall St. Rank held European Wax Center as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.